Media Coverage

Charles River, Fios Genomics Announce Partnership

3d render of dna structure, abstract  background.

Pharmaceutical Outsourcing

Through this partnership, Charles River clients will have access to Fios Genomics’ knowledge in bioinformatics, statistics and biology to assist in the sourcing and analysis of the high-dimensional, multi-variant datasets associated with drug development including microarrays, next-generation sequencing (NGS), proteomics, metabolomics and epigenetics as well as the associated meta-data. The biologically-relevant insights revealed by the team at Fios Genomics, combined with Charles River’s integrated drug discovery and development platform and the scientific expertise of both organizations, will enable Charles River clients to make more data-driven decisions about their programs, improving both confidence and speed.

Read the Full Article